Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted Therapeutic Candidate 1095 For the Treatment of Metastatic Prostate Cancer Pharmaceutical Investing
Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch Pharmaceutical Investing
Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome Pharmaceutical Investing
OncoMed Enrolls First Patient in Phase 1b Clinical Trial of its Anti-DLL4/VEGF Bispecific Antibody in Patients with Platinum-Resistant Ovarian Cancer Pharmaceutical Investing
Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine Pharmaceutical Investing
Ritter Pharmaceuticals Announces Collaboration with UBC to Explore Development of Microbiome Therapeutics in Environmental Enteropathy Pharmaceutical Investing
Intercept to Provide Update on Phase 3 REGENERATE Trial of Obeticholic Acid for the Treatment of NASH Patients with Liver Fibrosis Life Science Investing
M Pharmaceutical Inc. Provides Strategic Report to Shareholders Highlighting Acquisitions and Product Development Pharmaceutical Investing
Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017 Pharmaceutical Investing
